The doctors and scientists engaged in a long, and hitherto losing, struggle against the rise in diabetes and obesity around the world got excited this week. Who can blame them for bursting into applause as the promising clinical trial results of treatments to follow Novo Nordisk’s Wegovy drug were unveiled?Not only was there a new injectable formula that helped patients to lose up to 24 per cent of body weight in one trial, but the San Diego conference heard of fast progress towards pills that could work as effectively as the Danish group’s Wegovy and Ozempic. The overweight and obese, or at least those that can afford such pills, now have hope.
全世界许多医生和科学家对日渐增多的糖尿病和肥胖症进行了一场漫长但迄今依然失败的斗争，上周的一个消息无疑让他们感到了振奋。当诺和诺德(Novo Nordisk)生产的Wegovy（司美格鲁肽注射液）公布了看起来大有前景的临床试验结果时，谁能因为他们爆发出热烈的掌声而责怪他们呢？